A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: Vitamin D3 placebo CONDITION: Parkinson disease PRIMARY OUTCOME: changes of UPDRS, HY stage, MMSE SECONDARY OUTCOME: changes of PDQ‐39 and EQ‐5D INCLUSION CRITERIA: 1. Enrollment at Jikei University Aoto hospital 2. Obtained informed consent 3. Age 45 and more and less than 85 years old
Epistemonikos ID: 785ce4360f6b63d0486c94bf960e85bd2dac800d
First added on: Aug 22, 2024